AGAP2-AS1 as a prognostic biomarker in low-risk clear cell renal cell carcinoma patients with progressing disease

BACKGROUND: Clear cell renal cell carcinoma (ccRCC) is the most common subtype of renal cancer and one of the most common cancers. While survival for localized ccRCC is good, the survival of metastatic disease is not, and thirty percent of patients with ccRCC develop metastases during follow-up. Alt...

Descripción completa

Detalles Bibliográficos
Autores principales: Nakken, Sigrid, Eikrem, Øystein, Marti, Hans-Peter, Beisland, Christian, Bostad, Leif, Scherer, Andreas, Flatberg, Arnar, Beisvag, Vidar, Skandalou, Eleni, Furriol, Jessica, Strauss, Philipp
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Primary Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8686242/
https://www.ncbi.nlm.nih.gov/pubmed/34930263
http://dx.doi.org/10.1186/s12935-021-02395-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8686242/
https://www.ncbi.nlm.nih.gov/pubmed/34930263
http://dx.doi.org/10.1186/s12935-021-02395-9

Ejemplares similares